Global AI Adoption in Healthcare Accelerates as Readiness and Investment Surge

Healthcare organizations worldwide are prioritising artificial intelligence, with a new KLAS Research report finding AI listed among the top three investment priorities for the next two to three years in 43 countries. Leaders stress that foundational work—strategy, governance, data quality, and infrastructure—must precede tool deployment. Clinical documentation and diagnostic imaging are the most common early use cases, while ambient AI is generating the most excitement.

The market for AI‑driven medical imaging is projected to grow from $3.9 billion in 2025 to $204 billion by 2035, a compound annual growth rate of 17.7 %. Deep‑learning models are improving detection accuracy across radiology, cardiology, oncology and pathology, and major vendors such as Aidoc, Siemens Healthineers and Philips are expanding their AI portfolios.

Parallel trends are reshaping the supporting ecosystem. Data‑center capacity needed for AI workloads is expected to require $6.7 trillion of investment through 2030, with the four largest U.S. tech firms planning a 22 % annual growth in AI‑related data‑center spending. In India, AI is being deployed at scale to address diagnostic bottlenecks and to accelerate drug discovery, while industry analysts warn against over‑reliance on virtual AI executives that could replace human judgment.

Across clinical trials, AI is being applied to financial management to automate contract processing and reduce errors, illustrating the broader move toward AI‑enabled efficiency in both patient care and operational processes.